Grant: CIHR Fellowship
Direct Payment
$100,000.00
The role of cell type specific expression of Cadherin-11 in the calcification of aortic valve
FY 2015-16
Summary
Calcific aortic valve disease (CAVD) is among the most frequent valvular disorders by affecting nearly 25% of the elderly population in the developed countries. The major culprit of CAVD is characterized by progressive mineralization of the aortic valve for which there is currently no clinically useful biological diagnostics or pharmacological compound exists to either prevent or reduce the calcifying process. Cell-cell adhesion molecule, Cadherin-11, that is exclusively expressed in the adult valve endothelium cells (VECs) is re-expressed and re-activated in the valve interstitial cells (VICs) of CAVD patients. Its re-expression in VICs has been shown to induce nodule formation. However, how Cad-11 re-expression in VICs contributes to the process of calcification or if inhibition of Cad-11 would prevent mineral formation is largely unknown. In this study, we will investigate how cell-type specific Cad-11 expression contributes to valve remodeling and calcification and determine the specific downstream GTPase activity. Then we will clinically quantify Cad-11 and its isoform in the blood plasma of patients and determine its association to CAVD severity levels using patients' hemodynamic parameters. Lastly, we will screen a series of Cad-11 inhibitors for their potency and efficacy and determine if inhibition of Cad-11 inhibition would prevent calcification of the aortic valves. The result of this study elaborates a novel pathway that may be used as a diagnostic tool and targeted pharmaceutically. Although more sophisticated data is required, the presented approach will certainly contribute to the array of molecular biology of CAVD pathogenesis.
Department
Program
CIHR Fellowship
Recipient
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
339324
Name
Abulajiang Maihemuti
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
The role of cell type specific expression of Cadherin-11 in the calcification of aortic valve
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
3d Cellular And Tissue Culture; Calcific Aortic Valve Diseae; Calcification; Cardiovascular Disease; Dna/Rna Transfection; Elisa; Histological Studies; Mouse Model; Valve Endothelial Cells; Valve Interstitial Cells
Abstract
Calcific aortic valve disease (CAVD) is among the most frequent valvular disorders by affecting nearly 25% of the elderly population in the developed countries. The major culprit of CAVD is characterized by progressive mineralization of the aortic valve for which there is currently no clinically useful biological diagnostics or pharmacological compound exists to either prevent or reduce the calcifying process. Cell-cell adhesion molecule, Cadherin-11, that is exclusively expressed in the adult valve endothelium cells (VECs) is re-expressed and re-activated in the valve interstitial cells (VICs) of CAVD patients. Its re-expression in VICs has been shown to induce nodule formation. However, how Cad-11 re-expression in VICs contributes to the process of calcification or if inhibition of Cad-11 would prevent mineral formation is largely unknown. In this study, we will investigate how cell-type specific Cad-11 expression contributes to valve remodeling and calcification and determine the specific downstream GTPase activity. Then we will clinically quantify Cad-11 and its isoform in the blood plasma of patients and determine its association to CAVD severity levels using patients' hemodynamic parameters. Lastly, we will screen a series of Cad-11 inhibitors for their potency and efficacy and determine if inhibition of Cad-11 inhibition would prevent calcification of the aortic valves. The result of this study elaborates a novel pathway that may be used as a diagnostic tool and targeted pharmaceutically. Although more sophisticated data is required, the presented approach will certainly contribute to the array of molecular biology of CAVD pathogenesis.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Abulajiang, Maihemuti
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~